HUTCHINSON, Minn.--(BUSINESS WIRE)--Hutchinson Technology Incorporated (Nasdaq:HTCH) today announced the product launch and European CE Mark of its new InSpectra™ StO2 Tissue Oxygenation Monitor. This device gives hospital trauma teams the ability to noninvasively and continuously measure compromised tissue oxygen saturation (StO2) associated with hemorrhagic shock and monitor it during resuscitation.
